WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Regeneron and TriNetX announced a strategic collaboration giving Regeneron exclusive opportunity to connect genomic and proteomic cohorts with TriNetX’s de-identified electronic-health-record network. The arrangement includes secure licensed data access and a potential Regeneron investment of up to $200 million in TriNetX.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- International, International
- Source checked
- September 27, 2026
FOLLOW THE STORY